PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has announced its participation in the Oppenheimer 35th Annual Healthcare Life Sciences Conference. Dr. Jacqueline Shea, the company’s President and CEO, along with Dr. Michael Sumner, Chief Medical Officer, will deliver a presentation during the event scheduled for Wednesday, February 12, 2025, from 3:20 to 3:50 pm ET.
The presentation will provide insights into INOVIO’s ongoing advancements, with Dr. Shea and the management team also conducting one-on-one meetings with registered investors attending the conference.
A webcast of the presentation will be available on the INOVIO Investor Relations Events page, with a replay accessible for 90 days following the event.
This opportunity aims to keep investors informed about its progress and strategic direction in the healthcare and biotech space.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.